These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4015067)

  • 1. Antibacterial action of colistin (polymyxin E) against Mycobacterium aurum.
    David HL; Rastogi N
    Antimicrob Agents Chemother; 1985 May; 27(5):701-7. PubMed ID: 4015067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colistin (polymyxin E)--induced cell leakage in Mycobacterium aurum.
    Rastogi N; Henrotte JG; David HL
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Mar; 263(4):548-51. PubMed ID: 3604498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on colistin (polymyxin E)-induced cell leakage in mycobacteria: Mg++ efflux in Mycobacterium avium and its effects on drug-susceptibility.
    Rastogi N; Potar MC; Henrotte JG; Franck G; David HL
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):251-8. PubMed ID: 3394452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of colistin (polymyxin E) on the lytic cycle of the mycobacteriophage D29 in Mycobacterium tuberculosis.
    David HL; Rastogi N; Clavel-Sérès S; Clément F
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Sep; 262(3):321-34. PubMed ID: 3097989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins.
    Bardou F; Quémard A; Dupont MA; Horn C; Marchal G; Daffé M
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2459-67. PubMed ID: 8913447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial spectrum of colistin (polymixin E).
    Rastogi N; Potar MC; David HL
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(1):45-53. PubMed ID: 3674780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on clofazimine-resistance in mycobacteria: is the inability to isolate drug-resistance mutants related to its mode of action?
    David HL; Rastogi N; Clavel-Sérès S; Clément F
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Aug; 266(1-2):292-304. PubMed ID: 3122464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin causes profound morphological alteration but minimal cytoplasmic membrane perforation in populations of Escherichia coli and Pseudomonas aeruginosa.
    O'Driscoll NH; Cushnie TPT; Matthews KH; Lamb AJ
    Arch Microbiol; 2018 Jul; 200(5):793-802. PubMed ID: 29423561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis in vitro.
    van Breda SV; Buys A; Apostolides Z; Nardell EA; Stoltz AC
    Tuberculosis (Edinb); 2015 Jul; 95(4):440-6. PubMed ID: 26038290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
    Rastogi N; Labrousse V
    Antimicrob Agents Chemother; 1991 Mar; 35(3):462-70. PubMed ID: 1828135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin: Revival of an Old Polymyxin Antibiotic.
    Dijkmans AC; Wilms EB; Kamerling IM; Birkhoff W; Ortiz-Zacarías NV; van Nieuwkoop C; Verbrugh HA; Touw DJ
    Ther Drug Monit; 2015 Aug; 37(4):419-27. PubMed ID: 25549206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and chemical studies on wall-deficient forms, spheroplasts and membrane vesicles from Mycobacterium aurum.
    Rastogi N; David HL
    J Gen Microbiol; 1981 May; 124(1):71-9. PubMed ID: 7033468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis.
    Piddock LJ; Ricci V
    J Antimicrob Chemother; 2000 May; 45(5):681-4. PubMed ID: 10797093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
    Piddock LJ; Williams KJ; Ricci V
    J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance.
    Cheah SE; Li J; Tsuji BT; Forrest A; Bulitta JB; Nation RL
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3921-33. PubMed ID: 27067324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of polymyxins against dense populations of Escherichia coli.
    Greenwood D
    J Gen Microbiol; 1975 Nov; 91(1):110-8. PubMed ID: 172601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of inhibitors of cell envelope synthesis on beta-sitosterol side chain degradation by Mycobacterium sp. NRRL MB 3683.
    Sedlaczek L; Górmiński BM; Lisowska K
    J Basic Microbiol; 1994; 34(6):387-99. PubMed ID: 7815307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.
    Azzopardi EA; Ferguson EL; Thomas DW
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1837-43. PubMed ID: 25512401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.